# FDA 483 - Janssen Biotech, Inc. - March 05, 2018

Source: https://www.globalkeysolutions.net/records/483/janssen-biotech-inc/7bb1eae4-93cc-4e04-a24d-a92ba5419340

> FDA 483 for Janssen Biotech, Inc. on March 05, 2018. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Janssen Biotech, Inc.
- Inspection Date: 2018-03-05
- Product Type: biologics
- Office Name: Philadelphia District Office

## Related Documents

- [483 - 2025-07-29](https://www.globalkeysolutions.net/records/483/janssen-biotech-inc/91999c27-fff3-4a2e-af28-81a6a8053369)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/janssen-biotech-inc/7c521a84-767b-4adf-bb81-474b912533ba)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/janssen-biotech-inc/0157276e-6f1d-4c93-8304-a4d72eac3837)

## Related Officers

- [General Manager of Operations](https://www.globalkeysolutions.net/people/christopher-j-ewer/7865790c-c711-4253-83b1-492f20d6e831)
- [Investigator](https://www.globalkeysolutions.net/people/anita-r-michael/b7699b1a-4157-477e-8226-2cfc906fc61d)

Company: https://www.globalkeysolutions.net/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8